Abstract

OBJECTIVES:Approximately one-third of candidates for epilepsy surgery have no visible abnormalities on conventional magnetic resonance imaging. This is extremely discouraging, as these patients have a less favorable prognosis. We aimed to evaluate the utility of quantitative magnetic resonance imaging in patients with drug-resistant neocortical focal epilepsy and negative imaging.METHODS:A prospective study including 46 patients evaluated through individualized postprocessing of five quantitative measures: cortical thickness, white and gray matter junction signal, relaxation rate, magnetization transfer ratio, and mean diffusivity. Scalp video-electroencephalography was used to suggest the epileptogenic zone. A volumetric fluid-attenuated inversion recovery sequence was performed to aid visual inspection. A critical assessment of follow-up was also conducted throughout the study.RESULTS:In the subgroup classified as having an epileptogenic zone, individualized postprocessing detected abnormalities within the region of electroclinical origin in 9.7% to 31.0% of patients. Abnormalities outside the epileptogenic zone were more frequent, up to 51.7%. In five patients initially included with negative imaging, an epileptogenic structural abnormality was identified when a new visual magnetic resonance imaging inspection was guided by information gleaned from postprocessing. In three patients, epileptogenic lesions were detected after visual evaluation with volumetric fluid-attenuated sequence guided by video electroencephalography.CONCLUSION:Although quantitative magnetic resonance imaging analyses may suggest hidden structural lesions, caution is warranted because of the apparent low specificity of these findings for the epileptogenic zone. Conversely, these methods can be used to prevent visible lesions from being ignored, even in referral centers. In parallel, we need to highlight the positive contribution of the volumetric fluid-attenuated sequence.

Highlights

  • Epilepsy is defined as a brain disease defined by any of the following conditions: 1) at least two unprovoked seizures occurring 424h apart; 2) one unprovoked seizure and a probability of further seizures similar to the general recurrence risk after two unprovoked seizures, occurring over the 10 years; and 3) diagnosis of an epilepsy syndrome [1]

  • We aimed to evaluate the utility of quantitative magnetic resonance imaging in patients with drug-resistant neocortical focal epilepsy and negative imaging

  • In cases where previously unidentified epileptogenic structural lesions were detected during the time of data collection, we investigated whether the additional Magnetic resonance imaging (MRI) sequences allowed such detection and whether the new visual inspection was guided by another method, notably VEEG

Read more

Summary

Introduction

Epilepsy is defined as a brain disease defined by any of the following conditions: 1) at least two unprovoked (or reflex) seizures occurring 424h apart; 2) one unprovoked (or reflex) seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the 10 years; and 3) diagnosis of an epilepsy syndrome [1]. Symptomatic focal epilepsies account for approximately 60% of all cases, and approximately one-third of these patients present with drug-resistant epilepsy despite adequate trials of two tolerated, appropriately chosen and used antiepileptic drug regimens. Epilepsy surgery may be indicated for seizure control [3]. Magnetic resonance imaging (MRI) has emerged as an indispensable tool for the preoperative localization of epileptogenic lesions in people with drug-resistant epilepsy [3]. Important issues to consider during MRI evaluation of the epileptic patient, which may increase sensitivity for detecting structural abnormalities, include the use of specific protocols, expertise of the neuroradiologist, and use of the strongest magnetic field available [4,5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.